Miltefosine drug concerns

Comment

Subhash C Arya et al. Clin Infect Dis. 2013 Sep.

. 2013 Sep;57(6):917.

doi: 10.1093/cid/cit384. Epub 2013 Jun 11.

No abstract available

Comment in

Reply to Arya and Agarwal.
Dorlo TP, Ostyn BA, Beijnen JH, Boelaert M, Dujardin JC, Rijal S. Dorlo TP, et al. Clin Infect Dis. 2013 Sep;57(6):917-8. doi: 10.1093/cid/cit388. Epub 2013 Jun 11. Clin Infect Dis. 2013. PMID: 23759350 No abstract available.

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Rijal S, et al. Clin Infect Dis. 2013 Jun;56(11):1530-8. doi: 10.1093/cid/cit102. Epub 2013 Feb 20. Clin Infect Dis. 2013. PMID: 23425958